Frantz RP - Search Results

1

Advancing Risk Stratification in Pulmonary Arterial Hypertension Through Cardiac MRI: The Need for Collaboration and Standardization.

Frantz RP, Swift AJ. Frantz RP, et al. Chest. 2024 Jan;165(1):12-13. doi: 10.1016/j.chest.2023.10.038. Chest. 2024. PMID: 38199727 No abstract available.

2

Integration of clinical and hemodynamic parameters in the prediction of long-term survival in patients with pulmonary arterial hypertension.

Kane GC, Maradit-Kremers H, Slusser JP, Scott CG, Frantz RP, McGoon MD. Kane GC, et al. Among authors: frantz rp. Chest. 2011 Jun;139(6):1285-1293. doi: 10.1378/chest.10-1293. Epub 2010 Nov 11. Chest. 2011. PMID: 21071530

3

Right ventricular strain for prediction of survival in patients with pulmonary arterial hypertension.

Sachdev A, Villarraga HR, Frantz RP, McGoon MD, Hsiao JF, Maalouf JF, Ammash NM, McCully RB, Miller FA, Pellikka PA, Oh JK, Kane GC. Sachdev A, et al. Among authors: frantz rp. Chest. 2011 Jun;139(6):1299-1309. doi: 10.1378/chest.10-2015. Epub 2010 Dec 9. Chest. 2011. PMID: 21148241

4

Hemodynamic monitoring in pulmonary arterial hypertension.

Frantz RP. Frantz RP. Expert Rev Respir Med. 2011 Apr;5(2):173-8. doi: 10.1586/ers.11.16. Expert Rev Respir Med. 2011. PMID: 21510728 Review.

5

The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension.

Benza RL, Gomberg-Maitland M, Miller DP, Frost A, Frantz RP, Foreman AJ, Badesch DB, McGoon MD. Benza RL, et al. Among authors: frantz rp. Chest. 2012 Feb;141(2):354-362. doi: 10.1378/chest.11-0676. Epub 2011 Jun 16. Chest. 2012. PMID: 21680644

6

Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial.

Tapson VF, Torres F, Kermeen F, Keogh AM, Allen RP, Frantz RP, Badesch DB, Frost AE, Shapiro SM, Laliberte K, Sigman J, Arneson C, Galiè N. Tapson VF, et al. Among authors: frantz rp. Chest. 2012 Dec;142(6):1383-1390. doi: 10.1378/chest.11-2212. Chest. 2012. PMID: 22628490 Clinical Trial.

7

Impaired left ventricular mechanics in pulmonary arterial hypertension: identification of a cohort at high risk.

Hardegree EL, Sachdev A, Fenstad ER, Villarraga HR, Frantz RP, McGoon MD, Oh JK, Ammash NM, Connolly HM, Eidem BW, Pellikka PA, Kane GC. Hardegree EL, et al. Among authors: frantz rp. Circ Heart Fail. 2013 Jul;6(4):748-55. doi: 10.1161/CIRCHEARTFAILURE.112.000098. Epub 2013 May 24. Circ Heart Fail. 2013. PMID: 23709658

8

Pericardial effusions in pulmonary arterial hypertension: characteristics, prognosis, and role of drainage.

Fenstad ER, Le RJ, Sinak LJ, Maradit-Kremers H, Ammash NM, Ayalew AM, Villarraga HR, Oh JK, Frantz RP, McCully RB, McGoon MD, Kane GC. Fenstad ER, et al. Among authors: frantz rp. Chest. 2013 Nov;144(5):1530-1538. doi: 10.1378/chest.12-3033. Chest. 2013. PMID: 23949692

9

Hospitalization and survival in patients using epoprostenol for injection in the PROSPECT observational study.

Frantz RP, Schilz RJ, Chakinala MM, Badesch DB, Frost AE, McLaughlin VV, Barst RJ, Rosenberg DM, Miller DP, Hartline BK, Benton WW, Farber HW. Frantz RP, et al. Chest. 2015 Feb;147(2):484-494. doi: 10.1378/chest.14-1004. Chest. 2015. PMID: 25320967 Free PMC article.

10

Pulmonary Hypertension in Hereditary Hemorrhagic Telangiectasia.

Lyle MA, Fenstad ER, McGoon MD, Frantz RP, Krowka MJ, Kane GC, Swanson KL. Lyle MA, et al. Among authors: frantz rp. Chest. 2016 Feb;149(2):362-371. doi: 10.1378/chest.15-0535. Epub 2016 Jan 12. Chest. 2016. PMID: 26204445

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

193 results

Search Page